A leader in Indigenous dementia care, Jordan Lewis, PhD, MSW, associate director of the Memory Keepers Medical Discovery Team (MK-MDT), is partnering with the White Earth Band of Ojibwe to develop culturally safe dementia care resources for American Indian caregivers. 

Assistant Professor, Dr. Sandra Stover was recently elected to the 2021-2022 National Rural Health Association’s (NRHA) Rural Medical Education (RME) Executive Committee dedicated to advancing the training of physicians for rural practice through network development and advocacy.

The Minnesota Academy of Family Physicians (MAFP) recognized a University of Minnesota Medical School faculty member, alumni, a resident and medical student as part of its 2021 Academy Awards.

Drs. Kate Adamala, Sarah Heilbronner, Mark Thomas, Emilyn Alejandro and Esther Krook-Magnuson all received 2021 McKnight Awards.

A study led by researchers at the University of Minnesota Medical School sheds new light on boys’ weapon-carrying behaviors at U.S. high schools. The results indicate that weapon-carrying is not tied to students’ race or ethnicity but rather their schools’ social climates.

One year in, Drs. David Redish and Sophia Vinogradov share how their team secured one of the largest grants available from the National Institutes of Health.

Understanding the differences in COVID-19 vaccine immune response among immunocompromised patients is the focus of a new national study led, in part, by the University of Minnesota Medical School.

The American Bar Foundation is pleased to welcome Dr. Michele Statz to the 2021-2022 cohort of Access to Justice Scholars, bringing together research on how legal needs intersect with health outcomes in rural and Tribal communities. 

Michael Puskarich, MD, in the Department of Emergency Medicine, and Christopher Tignanelli, MD, MS, in the Department of Surgery, determined that the common blood pressure medication, losartan, is not effective in reducing hospitalization for mildly-ill COVID-19 outpatients. 

Two recent studies led by researchers from the University of Minnesota Medical School add new evidence to the impact of how drug price increases affect U.S. patients and the overall cost of health care.